SC Filed 2018-01-02 Event — SEC 0001144204-18-000215 →

IPSA (INNOVEN PARTENAIRES S.A.) → EYEGATE PHARMACEUTICALS INC KPHMW

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

9 13D/G filings on this issuer

8 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest

—

Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-17	Lane Keith J.	—	Award	55,000	$2.67	$147K

Other 13D/G Filings on EYEGATE PHARMACEUTICALS INC

Filed	Form	Filer	Stake	Shares
2026-09-17	SCHEDULE 13G	Baselake Partners, LP	—	—	view →
2021-08-03	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2021-01-12	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2020-01-15	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2019-10-18	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2019-10-02	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2019-04-04	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2018-01-17	SC	IPSA (INNOVEN PARTENAIRES S.A.)	—	—	view →

Other Filings by IPSA (INNOVEN PARTENAIRES S.A.)

Filed	Form	Issuer	Stake	Shares
2018-01-17	SC	EYEGATE PHARMACEUTICALS INC KPHMW	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →